Furthermore, scRNA-seq can uniquely distinguish rare cell types and cell states; for example, scRNA-seq datasets of T cells in adult gliomas revealed differences in the expression of cytotoxicity and stress pathways between IDH-mut and IDH-wt tumors that could not be identified via IHC or flow cytometry alone (131). Here, IDH1 is linked to central nervous system cancer.